Skip to main content
Log in

Cutaneous Adverse Effects of Lithium

Epidemiology and Management

  • Therapy in Practice
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Acneiform eruption, psoriasis, folliculitis, and maculopapular eruption have been described as adverse reactions to lithium therapy. In controlled studies, patients treated with lithium developed more cutaneous reactions, particularly acne and psoriasis, than patients receiving other psychotropics, with a prevalence in lithium-treated patients as high as 45%. Male patients taking lithium are more susceptible to developing cutaneous reactions than their female counterparts. Lithium tends to worsen or precipitate cutaneous conditions that are characterized by the pathological findings of neutrophilic infiltration. As lithium-related cutaneous adverse effects can be distressing to patients and may affect medication compliance, attention should be paid to skin problems in patients receiving lithium therapy. Management without cessation of lithium therapy is usually feasible except in some patients with psoriasis that is resistant to treatment. Paradoxically, therapeutic effects of topically applied lithium have been noted in seborrheic dermatitis and recurrent herpes infections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Table II

Similar content being viewed by others

References

  1. Cade JF. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 36: 349–52

    Google Scholar 

  2. El-Mallakh RS. Acute lithium neurotoxicity. Psychiatr Dev 1986; 4 (4): 311–28

    CAS  PubMed  Google Scholar 

  3. Callaway CL, Hendrie HC, Luby ED. Cutaneous conditions observed in patients during treatment with lithium. Am J Psychiatry 1968; 124 (8): 1124–5

    CAS  PubMed  Google Scholar 

  4. Kusumi Y. A cutaneous side effect of lithium: report of two cases. Dis Nerv Syst 1971; 32 (12): 853–4

    CAS  PubMed  Google Scholar 

  5. Carter TN. The relationship of lithium carbonate to psoriasis. Psychosomatics 1972; 13 (5): 325–7

    CAS  PubMed  Google Scholar 

  6. Chan HH, Wing Y, Su R, et al. A control study of the cutaneous side effects of chronic lithium therapy. J Affect Disord 2000; 57 (1–3): 107–13

    Article  CAS  PubMed  Google Scholar 

  7. Sarantidis D, Waters B. A review and controlled study of cutaneous conditions associated with lithium carbonate. Br J Psychiatry 1983; 143: 42–50

    Article  CAS  PubMed  Google Scholar 

  8. Heng MC. Cutaneous manifestations of lithium toxicity. Br J Dermatol 1982; 106 (1): 107–9

    Article  CAS  PubMed  Google Scholar 

  9. Mercke Y, Sheng H, Khan T, et al. Hair loss in psychopharmacology. Ann Clin Psychiatry 2000; 12 (1): 35–42

    CAS  PubMed  Google Scholar 

  10. Mortimer PS, Dawber RP. Hair loss and lithium. Int J Dermatol 1984; 23 (9): 603–4

    Article  CAS  PubMed  Google Scholar 

  11. Rubin MB. Lithium-induced Darier’s disease. J Am Acad Dermatol 1995; 32 (4): 674–5

    Article  CAS  PubMed  Google Scholar 

  12. Posey RE. Lithium carbonate dermatitis. JAMA 1972; 221 (13): 1517

    Article  CAS  PubMed  Google Scholar 

  13. Kuhnley EJ, Granoff AL. Exfoliative dermatitis during lithium treatment. Am J Psychiatry 1979; 136 (10): 1340–1

    CAS  PubMed  Google Scholar 

  14. Rifkin A, Kurtin SB, Quitkin F, et al. Lithium-induced folliculitis. Am J Psychiatry 1973; 130 (9): 1018–9

    CAS  PubMed  Google Scholar 

  15. Gupta AK, Knowles SR, Gupta MA, et al. Lithium therapy associated with hidradenitis suppurativa: case report and a review of the dermatologic side effects of lithium. J Am Acad Dermatol 1995; 32 (2 Pt 2): 382–6

    Article  CAS  PubMed  Google Scholar 

  16. Reiffers J, Dick P. Cutaneous side-effects of treatment with lithium. Dermatologica 1977; 155 (3): 155–63

    Article  CAS  PubMed  Google Scholar 

  17. McWhirter JD, Hashimoto K, Fayne S, et al. Linear IgA bullous dermatosis related to lithium carbonate. Arch Dermatol 1987; 123 (9): 1120–2

    Article  CAS  PubMed  Google Scholar 

  18. Shukla VR, Borison RL. Lithium and lupus like syndrome. JAMA 1982; 248 (8): 921–2

    Article  CAS  PubMed  Google Scholar 

  19. Fearfield LA, Bunker CB. Pityriasis versicolor associated with oral lithium therapy. Clin Exp Dermatol 1997; 22 (1): 57–9

    CAS  PubMed  Google Scholar 

  20. Evans DL, Martin W. Lithium carbonate and psoriasis. Am J Psychiatry 1979; 136 (10): 1326–7

    CAS  PubMed  Google Scholar 

  21. Skoven I, Thormann J. Lithium compound treatment and psoriasis. Arch Dermatol 1979; 115 (10): 1185–7

    Article  CAS  PubMed  Google Scholar 

  22. Lowe NJ, Ridgway HB. Generalized pustular psoriasis precipitated by lithium carbonate. Arch Dermatol 1978; 114 (12): 1788–9

    Article  CAS  PubMed  Google Scholar 

  23. Christodoulou GN, Georgala S, Vareltzides A, et al. Lithium in seborrheic dermatitis. Psychiatr J Univ Ott 1983; 8 (1): 27–9

    CAS  PubMed  Google Scholar 

  24. Vestergaard P, Amdisen A, Schou M. Clinically significant side effects of lithium treatment: a survey of 237 patients in long-term treatment. Acta Psychiatr Scand 1980; 62 (3): 193–200

    Article  CAS  PubMed  Google Scholar 

  25. DiGiovanna JJ, Aoyagi T, Taylor JR, et al. Inhibition of epidermal adenyl cyclase by lithium carbonate. J Invest Dermatol 1981; 76 (4): 259–63

    Article  CAS  PubMed  Google Scholar 

  26. Berridge MJ, Irvine RF. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 1984; 312 (5992): 315–21

    Article  CAS  PubMed  Google Scholar 

  27. Voorhees JJ, Duell EA. Psoriasis as a possible defect of the adenyl cyclase-cyclic AMP cascade: a defective chalone mechanism? Arch Dermatol 1971; 104 (4): 352–8

    Article  CAS  PubMed  Google Scholar 

  28. Voorhees JJ, Marcelo CL, Duell EA. Cyclic AMP, cyclic GMP, and glucocorticoids as potential metabolic regulators of epidermal proliferation and differentiation. J Invest Dermatol 1975; 65 (1): 179–90

    Article  CAS  PubMed  Google Scholar 

  29. Rothstein G, Clarkson DR, Larsen W, et al. Effect of lithium on neutrophil mass and production. N Engl J Med 1978; 298 (4): 178–80

    Article  CAS  PubMed  Google Scholar 

  30. Ockenfels HM, Wagner SN, Keim-Maas C, et al. Lithium and psoriasis: cytokine modulation of cultured lymphocytes and psoriatic keratinocytes by lithium. Arch Dermatol Res 1996; 288 (4): 173–8

    Article  CAS  PubMed  Google Scholar 

  31. Bloomfield FJ, Young MM. Enhanced release of inflammatory mediators from lithium-stimulated neutrophils in psoriasis. Br J Dermatol 1983 Jul; 109 (1): 9–13

    Article  CAS  PubMed  Google Scholar 

  32. Deandrea D, Walker N, Mehlmauer M, et al. Dermatological reactions to lithium: a critical review of the literature. J Clin Psychopharmacol 1982; 2 (3): 199–204

    Article  CAS  PubMed  Google Scholar 

  33. Rudolph RI. Lithium-induced psoriasis of the fingernails. J Am Acad Dermatol 1992; 26 (1): 135–6

    Article  CAS  PubMed  Google Scholar 

  34. Remmer HI, Falk WE. Successful treatment of lithium-induced acne [letter]. J Clin Psychiatry 1986; 47 (1): 48

    CAS  PubMed  Google Scholar 

  35. Malt U. Lithium carbonate and tetracycline interaction [letter]. BMJ 1978; 2 (6135): 502

    Article  CAS  PubMed  Google Scholar 

  36. Francis GJ, Silverman AR, Saleh O, et al. Follicular mycosis fungoides associated with lithium. J Am Acad Dermatol 2001; 44 (2): 308–9

    Article  CAS  PubMed  Google Scholar 

  37. Shukla S, Mukherjee S. Lichen simplex chronicus during lithium treatment. Am J Psychiatry 1984; 141 (7): 909–10

    CAS  PubMed  Google Scholar 

  38. Hoxtell E, Dahl MV. Xerosis from lithium carbonate [letter]. Arch Dermatol 1975; 111 (8): 1073–4

    Article  CAS  PubMed  Google Scholar 

  39. Srebrnik A, Bar-Nathan EA, Ilie B, et al. Vaginal ulcerations due to lithium carbonate therapy. Cutis 1991; 48 (1): 65–6

    CAS  PubMed  Google Scholar 

  40. Efalith Multicenter Trial Group. A double-blind, placebo-controlled, multicenter trial of lithium succinate ointment in the treatment of seborrheic dermatitis. J Am Acad Dermatol 1992; 26 (3 Pt 2): 452–7

    Article  Google Scholar 

  41. Langtry JA, Rowland Payne CM, Staughton RC, et al. Topical lithium succinate ointment (Efalith) in the treatment of AIDS-related seborrhoeic dermatitis. Clin Exp Dermatol 1997; 22 (5): 216–9

    Article  CAS  PubMed  Google Scholar 

  42. Horrobin DF. Lithium, fatty acid and seborrheic dermatitis: a new mechanism of lithium action and a new treatment for seborrheic dermatitis. Lithium 1990; 1: 149–55

    CAS  Google Scholar 

  43. Skinner GR. Lithium ointment for genital herpes [letter]. Lancet 1983; II: 288

    Article  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this manuscript. The authors have no conflicts of interest that are directly relevant to the content of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Henry Hin Lee Chan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yeung, C.K., Chan, H.H.L. Cutaneous Adverse Effects of Lithium. Am J Clin Dermatol 5, 3–8 (2004). https://doi.org/10.2165/00128071-200405010-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200405010-00002

Keywords

Navigation